Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies
- PMID: 35133616
- DOI: 10.1007/s40618-022-01754-1
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies
Abstract
Purpose: Cushing's disease (CD), 70% of endogenous hypercortisolism cases, is a rare disease caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas. To date, no systematic reviews and meta-analyses on its global epidemiology have been published. We provide a systematic review and meta-analysis of CD global epidemiology, also evaluating the quality of study reporting for the identified studies.
Methods: MEDLINE and EMBASE databases were searched for studies on CD epidemiology from inception until November 30th, 2020, including original observational studies in English about CD prevalence and/or incidence for well-defined geographic areas. Two reviewers independently extracted data and assessed reporting quality. CD prevalence/incidence pooled estimates were derived from a random-effects meta-analysis. Reporting quality was assessed using a STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist adapted for observational studies on rare diseases, heterogeneity using the Cochran's Q-test and its derived measure of inconsistency (I2).
Results: Thirteen studies were included. The pooled CD prevalence was 2.2 [95% CI 1.1-4.8] per 100,000, while the incidence rate was 0.24 [95% CI 0.15-0.33] per 100,000 person-years. For both parameters, considerable between-studies heterogeneity was found (I2 = 78.8% and 87.8%, respectively). The quality of study reporting was rated as medium for 11 (84.6%) studies and as low for 2 (15.4%).
Conclusion: Overall, our systematic meta-analysis demonstrated CD epidemiology to be similarly reported across different areas of the world, with some exceptions regarding regional differences or observation period intervals. Keeping into account the methodological differences between each paper, large-scale studies on CD epidemiology are warranted. Setting up national specific registries, based on standardized diagnostic and clinical parameters, with clearly defined selection and analysis criteria, and a strong cooperation between the scientific national societies for endocrinology is crucial to exclude other causes of variability (i.e. geographical differences due to other factors like (epi)genetic changes), and to support public health decision making.
Keywords: ACTH-dependent hypercortisolism; ACTH-secreting PitNETs; Cushing’s disease.
© 2022. Italian Society of Endocrinology (SIE).
Similar articles
-
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8. Orphanet J Rare Dis. 2020. PMID: 32503598 Free PMC article.
-
Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].Endocr J. 2014;61(10):941-8. doi: 10.1507/endocrj.ej14-0120. Epub 2014 Jun 29. Endocr J. 2014. PMID: 24974880 Review.
-
Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2022 Jul 1;13:935759. doi: 10.3389/fendo.2022.935759. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846311 Free PMC article.
-
Epidemiology and mortality of Cushing's syndrome.Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101521. doi: 10.1016/j.beem.2021.101521. Epub 2021 Mar 15. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 33766428 Review.
-
Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.Neurosurg Focus. 2015 Feb;38(2):E12. doi: 10.3171/2014.10.FOCUS14705. Neurosurg Focus. 2015. PMID: 25639314
Cited by
-
Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies.J Endocrinol Invest. 2025 Jul 2. doi: 10.1007/s40618-025-02639-9. Online ahead of print. J Endocrinol Invest. 2025. PMID: 40601232 Review.
-
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib.J Clin Endocrinol Metab. 2023 Feb 15;108(3):726-735. doi: 10.1210/clinem/dgac588. J Clin Endocrinol Metab. 2023. PMID: 36214832 Free PMC article.
-
Prediction of remission and recurrence of Cushing's disease following transsphenoidal surgery (TSS): a single center, 20-year, retrospective series.Endocrine. 2025 Jun 18. doi: 10.1007/s12020-025-04304-w. Online ahead of print. Endocrine. 2025. PMID: 40531432
-
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing's disease: a monocentric experience in Southern Italy.J Endocrinol Invest. 2023 Aug;46(8):1711-1715. doi: 10.1007/s40618-023-02016-4. Epub 2023 Jan 28. J Endocrinol Invest. 2023. PMID: 36708457 Free PMC article.
-
Mutual associations among responsiveness to differential diagnostic tests for Cushing's disease, tumor size, and somatostatin receptor 5 expression in corticotroph tumors.Endocr J. 2025 Jan 6;72(1):93-102. doi: 10.1507/endocrj.EJ24-0344. Epub 2024 Oct 24. Endocr J. 2025. PMID: 39443112 Free PMC article.
References
-
- Juszczak A, Morris D, Grossman A (2000) Cushing’s syndrome [internet]. Endotext
-
- Nieman LK (2015) Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol 173:33–38 - DOI
-
- Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P et al (2011) The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383–392 - DOI
-
- Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U et al (2001) Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117–123 - PubMed
-
- Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol 40:479–484 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources